Literature DB >> 24290063

From NMDA receptor antagonists to discovery of selective σ₂ receptor ligands.

Rosaria Gitto1, Laura De Luca2, Stefania Ferro2, Angela Scala3, Simone Ronsisvalle4, Carmela Parenti4, Orazio Prezzavento4, Maria Rosa Buemi2, Alba Chimirri2.   

Abstract

Following previous studies focused on the search for new molecules targeting GluN2B-containing NMDA, a small series of 1-(1H-indol-3-yl)-2-(4-phenylpiperidin-1-yl)ethanone derivatives has been synthesized by using Microwave Assisted Organic Synthesis (MAOS). Given that GluN2B ligands frequently exert off-target effects we also tested their affinity towards sigma receptors. Binding assay revealed that only the 1-(5-hydroxy-1H-indol-3-yl)-2-(4-phenylpiperidin-1-yl)ethanone (7a) retained GluN2B affinity. Interestingly, the 5-methoxyindoles 5a and 6a were efficient and selective ligands toward σ₂ receptor (Ki values of 10nM and 20 nM, respectively). Thus, in this case the discovery of new σ₂ receptor selective ligands was an unexpected result emerging from the screening of cross-activity against other CNS receptors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GluN2B/NMDA; Glutamate; Ifenprodil; Indoles; Sigma receptor

Mesh:

Substances:

Year:  2013        PMID: 24290063     DOI: 10.1016/j.bmc.2013.11.014

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

Review 1.  Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?

Authors:  José Miguel Vela
Journal:  Front Pharmacol       Date:  2020-11-09       Impact factor: 5.810

2.  QSAR-Based Computational Approaches to Accelerate the Discovery of Sigma-2 Receptor (S2R) Ligands as Therapeutic Drugs.

Authors:  Yangxi Yu; Hiep Dong; Youyi Peng; William J Welsh
Journal:  Molecules       Date:  2021-08-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.